These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

450 related items for PubMed ID: 23347652

  • 1. PDGFB rearrangement in dermatofibrosarcoma protuberans: correlation with clinicopathologic characteristics and clinical implications.
    Ha SY, Lee SE, Kwon MJ, Kim YJ, Lee EH, Seo J, Jang KT, Lee J, Choi YL.
    Hum Pathol; 2013 Jul; 44(7):1300-9. PubMed ID: 23347652
    [Abstract] [Full Text] [Related]

  • 2. Identification of t(17;22)(q22;q13) (COL1A1/PDGFB) in dermatofibrosarcoma protuberans by fluorescence in situ hybridization in paraffin-embedded tissue microarrays.
    Segura S, Salgado R, Toll A, Martín-Ezquerra G, Yébenes M, Sáez A, Solé F, Barranco C, Umbert P, Espinet B, Pujol RM.
    Hum Pathol; 2011 Feb; 42(2):176-84. PubMed ID: 21111450
    [Abstract] [Full Text] [Related]

  • 3. Dermatofibrosarcoma protuberans COL1A1-PDGFB fusion is identified in virtually all dermatofibrosarcoma protuberans cases when investigated by newly developed multiplex reverse transcription polymerase chain reaction and fluorescence in situ hybridization assays.
    Patel KU, Szabo SS, Hernandez VS, Prieto VG, Abruzzo LV, Lazar AJ, López-Terrada D.
    Hum Pathol; 2008 Feb; 39(2):184-93. PubMed ID: 17950782
    [Abstract] [Full Text] [Related]

  • 4. Transformed dermatofibrosarcoma protuberans: real time polymerase chain reaction detection of COL1A1-PDGFB fusion transcripts in sarcomatous areas.
    Szollosi Z, Scholtz B, Egervari K, Nemes Z.
    J Clin Pathol; 2007 Feb; 60(2):190-4. PubMed ID: 16731589
    [Abstract] [Full Text] [Related]

  • 5. Application of COL1A1-PDGFB fusion gene detection by fluorescence in situ hybridization in biopsy tissue of dermatofibrosarcoma protuberans.
    Zhang Z, Chen H, Chen M, He X, Wang Y, Zhang H.
    J Dermatol; 2017 Jul; 44(7):798-802. PubMed ID: 28150334
    [Abstract] [Full Text] [Related]

  • 6. Plaque-like CD34-positive dermal fibroma ("medallion-like dermal dendrocyte hamartoma"): clinicopathologic, immunohistochemical, and molecular analysis of 5 cases emphasizing its distinction from superficial, plaque-like dermatofibrosarcoma protuberans.
    Kutzner H, Mentzel T, Palmedo G, Hantschke M, Rütten A, Paredes BE, Schärer L, Guillen CS, Requena L.
    Am J Surg Pathol; 2010 Feb; 34(2):190-201. PubMed ID: 20061935
    [Abstract] [Full Text] [Related]

  • 7. Genomic gains of COL1A1-PDFGB occur in the histologic evolution of giant cell fibroblastoma into dermatofibrosarcoma protuberans.
    Macarenco RS, Zamolyi R, Franco MF, Nascimento AG, Abott JJ, Wang X, Erickson-Johnson MR, Oliveira AM.
    Genes Chromosomes Cancer; 2008 Mar; 47(3):260-5. PubMed ID: 18069662
    [Abstract] [Full Text] [Related]

  • 8. A novel fusion gene of collagen type I alpha 1 (exon 31) and platelet-derived growth factor B-chain (exon 2) in dermatofibrosarcoma protuberans.
    Nakanishi G, Lin SN, Asagoe K, Suzuki N, Matsuo A, Tanaka R, Makino E, Fujimoto W, Iwatsuki K.
    Eur J Dermatol; 2007 Mar; 17(3):217-9. PubMed ID: 17478383
    [Abstract] [Full Text] [Related]

  • 9. Myxoid dermatofibrosarcoma protuberans: clinicopathologic, immunohistochemical, and molecular analysis of eight cases.
    Mentzel T, Schärer L, Kazakov DV, Michal M.
    Am J Dermatopathol; 2007 Oct; 29(5):443-8. PubMed ID: 17890911
    [Abstract] [Full Text] [Related]

  • 10. PDGFB Rearrangements in Dermatofibrosarcoma Protuberans of the Vulva: A Study of 11 Cases Including Myxoid and Fibrosarcomatous Variants.
    Jahanseir K, Xing D, Greipp PT, Sukov WR, Keeney GL, Howitt BE, Schoolmeester JK.
    Int J Gynecol Pathol; 2018 Nov; 37(6):537-546. PubMed ID: 29140881
    [Abstract] [Full Text] [Related]

  • 11. Molecular diagnosis of dermatofibrosarcoma protuberans: a comparison between reverse transcriptase-polymerase chain reaction and fluorescence in situ hybridization methodologies.
    Salgado R, Llombart B, M Pujol R, Fernández-Serra A, Sanmartín O, Toll A, Rubio L, Segura S, Barranco C, Serra-Guillén C, Yébenes M, Salido M, Traves V, Monteagudo C, Sáez E, Hernández T, de Álava E, Llombart-Bosch A, Solé F, Guillén C, Espinet B, López-Guerrero JA.
    Genes Chromosomes Cancer; 2011 Jul; 50(7):510-7. PubMed ID: 21484928
    [Abstract] [Full Text] [Related]

  • 12. Dermatofibrosarcoma protuberans: a clinicopathological, immunohistochemical, genetic (COL1A1-PDGFB), and therapeutic study of low-grade versus high-grade (fibrosarcomatous) tumors.
    Llombart B, Monteagudo C, Sanmartín O, López-Guerrero JA, Serra-Guillén C, Poveda A, Jorda E, Fernandez-Serra A, Pellín A, Guillén C, Llombart-Bosch A.
    J Am Acad Dermatol; 2011 Sep; 65(3):564-575. PubMed ID: 21570152
    [Abstract] [Full Text] [Related]

  • 13. Molecular and clinicopathological analysis of dermatofibrosarcoma protuberans.
    Walluks K, Chen Y, Woelfel C, Yang L, Cui T, Seliger C, Geier C, Knösel T, Hauke S, Petersen I.
    Pathol Res Pract; 2013 Jan 15; 209(1):30-5. PubMed ID: 23207290
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. COL1A1-PDGFB fusion transcripts in fibrosarcomatous areas of six dermatofibrosarcomas protuberans.
    Wang J, Morimitsu Y, Okamoto S, Hisaoka M, Ishida T, Sheng W, Hashimoto H.
    J Mol Diagn; 2000 Feb 15; 2(1):47-52. PubMed ID: 11272901
    [Abstract] [Full Text] [Related]

  • 17. Dermatofibrosarcoma protuberans: clinical, pathological, and genetic (COL1A1-PDGFB ) study with therapeutic implications.
    Llombart B, Sanmartín O, López-Guerrero JA, Monteagudo C, Serra C, Requena C, Poveda A, Vistós JL, Almenar S, Llombart-Bosch A, Guillén C.
    Histopathology; 2009 Jun 15; 54(7):860-72. PubMed ID: 19635106
    [Abstract] [Full Text] [Related]

  • 18. [From cytogenetics to cytogenomics of dermatofibrosarcoma protuberans family of tumors].
    Bianchini L, Maire G, Pedeutour F, Groupe Francophone de Cytogénétique Oncologique.
    Bull Cancer; 2007 Feb 15; 94(2):179-89. PubMed ID: 17337387
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.